Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Org 50081 (esmirtazapine) for vasomotor symptoms in postmenopausal women
2004-000469-36Phase 2Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of esmirtazapine in menopause (5 arms), sponsored by Organon & Co. Primary endpoint: Change in frequency of moderate to severe vasomotor symptoms at Week 4. Started Aug 2004; status: completed.
02
Drugs
esmirtazapine
03
Conditions
menopause
Beyond the preview
Go deeper on 2004-000469-36.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000469-36.